DUTASTERID Tamsulosin Zentiva 0.5/0.4mg bte 7 pce

7680679590014 CH-67959 G04CA52 05.99.0.
DUTASTERID Tamsulosin Zentiva 0.5/0.4mg bte 7 pce
DUTASTERID Tamsulosin Zentiva 0.5/0.4mg bte 7 pce
DUTASTERID Tamsulosin Zentiva 0.5/0.4mg bte 7 pce
1 / 3
google

Details

Product number
6795901
CPT
-
Packaging group
7
Unit
Kapsel(n)
Composition
dutasteridum 0.5 mg, tamsulosini hydrochloridum 0.4 mg corresp. tamsulosinum 0.367 mg, Dutasterid-Weichkapsel innerhalb der Hartkapsel: propylenglycoli dicaprylocapras 299.46 mg corresp. propylenglycolum 112.8 mg, E 321, gelatina, E 171, glycerolum, triglycerida media, lecithinum ex soja q.s., Tamsulosin-Pellets in Hartkapsel: cellulosum microcristallinum, acidi methacrylici et ethylis acrylatis polymerisatum 1:1 cum polysorbatum 80 et natrii laurilsulfas corresp. natrium 0.09 mg, dibutylis sebacas, silica colloidalis hydrica, calcii stearas, Kapselhülle: E 172 (nigrum), E 172 (rubrum), E 171, E 172 (flavum), gelatina, Drucktinte: lacca, E 172 (nigrum), propylenglycolum, ammoniae solutio concentrata, kalii hydroxidum, pro capsula.

Articles (1)

Dutasterid Tamsulosin Zentiva 0.5 mg/ 0.4 mg, Kapseln
Kapseln
7
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
24/06/2024
Patient information leaflet
Français
24/06/2024
Patient information leaflet
Italien
24/06/2024
Professional SmPC
Allemand
15/04/2021
Professional SmPC
Français
15/04/2021
Professional SmPC
Italien
15/04/2021

Detailed composition

Substance Quantity Type Category
(N/A)
0.5 MG Substance Wirkstoff (Principe actif)
(N/A)
0.4 MG Substance WIZUS
(N/A)
0.367 MG Substance Wirkstoff (Principe actif)
(N/A)
299.46 MG Substance HBESI
(N/A)
112.8 MG Substance HBESI
(N/A)
- Substance ANTOX
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
0.09 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK
(N/A)
- Substance FNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 13.25
Specialties list
Yes
Generic
Yes
SL addition date: 01/05/2021

Authorization holder

Helvepharm AG

8500 Frauenfeld

Authorization information

Swissmedic authorization number
67959
Drug name
Dutasterid Tamsulosin Zentiva, Kapseln
Galenic form
KAHA
ATC Code
G04CA52
Authorization status
Z
Dispensation category
B
First authorization
12/10/2020
Authorization expiration date
31/12/9999
IT number
05.99.0.
Domain
Human medicine
Field of application
Benigne Prostatahyperplasie

Packaging details

Description (FR)
DUTASTERID Tamsulosin Zentiva 0.5/0.4mg bte 7 pce
Description (DE)
DUTASTERID Tamsulosin Zentiva 0.5/0.4mg Ds 7 Stk
Market launch
12/10/2020
Narcotic (BTM)
No

Original drug

Duodart, Hartkapseln
CHF 49.90
View original

Other packaging sizes

DUTASTERID Tamsulosin Zentiva 0.5/0.4mg bte 30 pce
30 KAP
View
DUTASTERID Tamsulosin Zentiva 0.5/0.4mg bte 90 pce
90 KAP
View